Switching to IV methadone (IV-ME) can provide pain relief in patients with cancer who fail to receive sufficient analgesic effects from oral opioids, according to recent data.
A retrospective analysis included 47 patients who were prescribed IV-ME during admissions to an acute supportive/palliative care unit (ASPCU) between January 2018 and November 2022 (J Pain Symptom Manage 2023 May 25. doi:10.1016/j.jpainsymman.2023.04.026). Poor analgesia with oral methadone and/or other opioids and/or